Pharvaris

Orally deliverable bradykinin B2 antagonists for hereditary angioedema

placeLeiden, South Holland, Netherlands calendar_todayFounded 2015 groups66 employees language pharvaris.com

Social engagement

Social engagement: 12K social following, 8 posts in the last 12 months — above the industry median.

Investor mix

11 investors on record; lead investors include Foresite Capital, Life Sciences Partners, Idinvest Partners, Kurma Partners; 4 have since exited.

Investor typeCountShare
Venture capital545%
Private equity545%
Accelerator & incubator19%

Hiring activity

Hires periodically

9 roles tracked across 4 of the last 12 months

23 Jun 2026 · Commercial Insights and Analytics Lead · U.S.

10 Jun 2026 · Director, US Commercial QA Lead (GMP) · Lexington

4 Jun 2026 · Thought Leader Liaison (TLL) · Northeast, Southeast, Central, West (all U.S.-based, remote/

29 May 2026 · Thought Leader Liaison (TLL), West · Denver

14 Feb 2026 · Medical Science Liaison - Midwest · Minneapolis

Based on job postings tracked across public sources.

Recent activity

18 Jun 2026
Event
Beat Allergy Walk & Run
15 Jun 2026
Event
European Academy of Allergy and Clinical Immunology - EAACI Annual Congress 2026
5 Jun 2026
Event
2026 World Orphan Drug Congress
Coming soon